Fate Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Fate Therapeutics (NASDAQ: FATE), a clinical-stage biopharmaceutical company focused on iPSC-derived cellular immunotherapies for cancer and autoimmune diseases, has announced its participation in four major upcoming investor conferences in February and March 2025:

• H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Fireside chat on February 25 at 1:30 PM ET
• TD Cowen 45th Annual Health Care Conference - Company presentation in Boston on March 3 at 11:50 AM ET
• Barclays 27th Annual Global Healthcare Conference - Fireside chat in Miami on March 11 at 8:30 AM ET
• Leerink Partners Global Healthcare Conference - Fireside chat in Miami on March 12 at 11:20 AM ET

Live webcasts of the presentations, when available, can be accessed through the Investors section of Fate Therapeutics' website under 'Events & Presentations,' with archived recordings available shortly after each event.

SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will participate in the following upcoming investor conferences:

• H.C. Wainwright 3^rd Annual Cell Therapy Virtual Conference, including a fireside chat at 1:30 PM ET on Tuesday, February 25, 2025
  
• TD Cowen 45^th Annual Health Care Conference, including a company presentation at 11:50 AM ET on Monday, March 3, 2025 in Boston, Massachusetts
  
• Barclays 27^th Annual Global Healthcare Conference, including a fireside chat at 8:30 AM ET on Tuesday, March 11, 2025 in Miami, Florida
  
• Leerink Partners Global Healthcare Conference, including a fireside chat at 11:20 AM ET on Wednesday, March 12, 2025 in Miami, Florida
  

A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.

About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s pipeline includes iPSC-derived natural killer (NK) cell and T-cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Contact:
Christina Tartaglia
Precision AQ
212.362.1200
christina.tartaglia@precisionaq.com

FAQ

What investor conferences will Fate Therapeutics (FATE) attend in early 2025?

Fate Therapeutics will attend four conferences: H.C. Wainwright Cell Therapy Virtual Conference (Feb 25), TD Cowen Health Care Conference (March 3), Barclays Global Healthcare Conference (March 11), and Leerink Partners Global Healthcare Conference (March 12).

How can investors access Fate Therapeutics' conference presentations in 2025?

Investors can access live webcasts of the presentations through the 'Events & Presentations' section in the Investors area of Fate Therapeutics' website (www.fatetherapeutics.com). Archived recordings will be available shortly after each event.

What types of therapeutic developments will FATE discuss at the 2025 conferences?

Fate Therapeutics is expected to discuss their first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for cancer and autoimmune diseases.

Where will Fate Therapeutics' in-person conference presentations take place in March 2025?

The in-person presentations will take place in Boston, Massachusetts (TD Cowen Conference on March 3) and Miami, Florida (Barclays Conference on March 11 and Leerink Partners Conference on March 12).